Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

24/04/2026 09:00

Apr 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              321.75              288.46                     
                   (+11.5 pct)         (+21.7 pct)                  
  Operating          158.77              136.65                     
                   (+16.2 pct)         (+36.8 pct)                  
  Pretax
  Net                115.42               97.23                     
                   (+18.7 pct)         (+30.7 pct)                  
  EPS Basic         70.13 yen           59.09 yen                   
  EPS Diluted       70.13 yen           59.08 yen                   
  Ann Div                              272.00 yen       132.00 yen  
  -Q2 Div                              125.00 yen        66.00 yen  
  -Q4 Div                              147.00 yen        66.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T